Pontifax is a healthcare-focused venture capital firm seeking transformative, cutting-edge life-sciences technologies in all therapeutic areas and development stages. Its portfolio comprises approximately 80 companies developing breakthrough solutions for significant unmet needs. Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage. It establishes its own companies and partners with existing management to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company. Pontifax began with the vision of its co-founder and chairman, Eli Hurvitz, the CEO and chairman of Teva Pharmaceuticals.